Yoshihisa Umekita

Papers

Total Citations

H-Index

About

Yoshihisa Umekita is a distinguished urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the refinement of surgical techniques and prognostic markers. His work centers on the clinical implications of positive surgical margins following robot-assisted radical prostatectomy, a minimally invasive procedure for localized prostate cancer. In his most-cited study (2021, 24 citations), Umekita demonstrated that positive surgical margins are a significant predictor of early biochemical recurrence, providing critical insights for postoperative risk stratification and treatment planning. This contribution has helped urologists identify patients who may benefit from closer surveillance or adjuvant therapy. Beyond this landmark paper, Umekita has advanced the understanding of surgical quality metrics and their impact on long-term oncologic control. His research bridges the gap between surgical precision and patient outcomes, offering practical guidance for clinicians. With a growing citation footprint, Umekita continues to shape the field of robotic urologic surgery, making his work essential reading for researchers and surgeons dedicated to optimizing prostate cancer care.